Abstract:Objective\r\nThis multi-center study aims to investigate the PSA level, prostate volume, biopsy scheme and biopsy method of patients receiving prostate biopsy in Chinese Prostate Cancer Consortium (CPCC) hospitals and identify the detection rate of prostate cancer (PCa) in different PSA ranges in Chinese.\r\n\r\n\r\nMethods\r\nDetailed clinical information of consecutive patients underwent prostate biopsy in 33 CPCC hospitals were recorded with EpiData Entry 3.1. Those information included PSA level, prostate volume, biopsy scheme and biopsy method. All statistics analysis was performed with SPSS 17.0. T test was applied to compare age between different groups. Mann-Whitney U test was applied to compare PSA, prostate volume, and percent free PSA.\r\n\r\n\r\nResults\r\nA total of 19292 cases were collected. After excluding cases with factors that would influence PSA level, 13904 cases from 22 hospitals were involved in further investigation. The medium volume of prostate was 44.0ml (range 31.1~65.5 ml). The distribution of patients in different PSA level included 701 cases (5%) in PSA 50.0 μg/L. There were 10808 cases who underwent transrectal ultrasound-guided prostate biopsy and 3087 cases who underwent transperineal biopsy. There were 312(2%), 1436(10%), 2640(19%), 3920(28%), 4989(36%) and 607(4%) cases who underwent non-systematic biopsy, 6-, 8-, 10-, 12- core and saturation biopsy, respectively. PCa detection rates were 44%, 26% and 35% in all patients, patients with PSA 4.1-10.0 μg/L and 10.1-20.0 μg/L, respectively. The distribution of Gleason scores in those patients with positive biopsy included the 1295 cases (21%) with less than 7 scores, 1164 cases (19%) with 3+ 4 scores, 1155 cases (19%) with 4+ 3 scores, 2371 cases with more than 8 scores and 138 cases (2%) with uncertain scores.\r\n\r\n\r\nConclusion\r\nThe most widely applied biopsy scheme in CPCC hospitals is transrectal ultrasound-guided biopsy. The PSA level of patients in CPCC hospitals is relatively high. The relationship between PSA level and PCa detection rate in Chinese population is different from reports in Western population.\r\n\r\n\r\nKey words: \r\nProstatic neoplasms; Early diagnosis; Prostate-specific antigen; Prostate biopsy

The Use of Prostate Specific Antigen (PSA) Density in Detecting Prostate Cancer in Chinese Men with PSA Levels of 4–10 Ng/ml

Significance of prostate-specific antigen density for detecting prostate cancer in men with serum PSA levels of 4～10 ng

Age-Specific Cutoff Value for the Application of Percent Free Prostate-Specific Antigen (PSA) in Chinese Men with Serum PSA Levels of 4.0-10.0 Ng/ml.

PSA Density Improves the Rate of Prostate Cancer Detection in Chinese Men with a PSA Between 2.5-10.0 Ng Ml (-1) and 10.1-20.0 Ng Ml (-1) : a Multicenter Study.

Percent Free Prostate-Specific Antigen for Prostate Cancer Diagnosis in Chinese Men with a PSA of 4.0–10.0 Ng/ml: Results from the Chinese Prostate Cancer Consortium

The Utility of Complexed Prostate Specific Antigen Density(cPSAD) for Early Detection Proatate Cancer in Han Population with Different Serum PSA Levels

[The Detection Rate of Prostate Cancer in Different Prostate-Specific Antigen (PSA) Levels in Chinese Men].

Transition Zone PSA Density Improves the Prostate Cancer Detection Rate Both in PSA 4.0-10.0 and 10.1-20.0 Ng/ml in Chinese Men

Peripheral Zone PSA Density: a Predominant Variable to Improve Prostate Cancer Detection Efficiency in Men with PSA Higher Than 4 Ng Ml-1.

Ratio of initial prostate specific antigen to free prostate specific antigen on diagnosis of prostate carcinoma in Chinese men during post-prostate specific antigen era

Age-Specific Prostate Specific Antigen Cutoffs For Guiding Biopsy Decision In Chinese Population

Study of Prostate Specific Antigen Relevant Parameters in Prostate Cancer by Three-Dimensional Transrectal Ultrasonography

Evaluation of PSA-age Volume Score in Predicting Prostate Cancer in Chinese Population

The value of adjusted PSAD in prostate cancer detection in the Chinese population

The Influence of Prostate Volume on Cancer Detection in the Chinese Population.

Prostate-specific antigen (PSA) density in the diagnostic algorithm of prostate cancer

Ethnic differences in distribution of serum prostate-specific antigen: a study in a healthy Chinese male population.

Prostate-specific Antigen Velocity (PSAV) and PSAV Per Initial Volume (PSAVD) for Early Detection of Prostate Cancer in Chinese Men.

Percent Free Prostate-Specific Antigen Is Effective To Predict Prostate Biopsy Outcome In Chinese Men With Prostate-Specific Antigen Between 10.1 And 20.0 Ng Ml(1)

Current status of prostate biopsy in Chinese Prostate Cancer Consortium member hospitals

Additional Value of the Ratio of Serum Total Testosterone to Total Prostate-Specific Antigen in the Diagnosis of Prostate Cancer in a Chinese Population